Hamostaseologie

Papers
(The TQCC of Hamostaseologie is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH143
Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis68
Factor XI as a Target for New Anticoagulants48
Platelets and COVID-1947
Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE—Position Paper of the Working Group in Women's Health 26
Head, Neck, and Abdominopelvic Septic Thrombophlebitis: Current Evidence and Challenges in Diagnosis and Treatment26
Platelet Shape Changes during Thrombus Formation: Role of Actin-Based Protrusions26
Acquired von Willebrand Syndrome and Platelet Function Defects during Extracorporeal Life Support (Mechanical Circulatory Support)24
Platelet Purinergic Receptors in Thrombosis and Inflammation22
Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?21
Navigating the Myriad of von Willebrand Factor Assays20
Ovarian Vein Thrombosis: A Narrative Review20
Platelets in Thrombo-Inflammation: Concepts, Mechanisms, and Therapeutic Strategies for Ischemic Stroke20
Practical Guidance of the GTH Haemophilia Board on the Use of Emicizumab in Patients with Haemophilia A19
Does One Dose Really Fit All? On the Monitoring of Direct Oral Anticoagulants: A Review of the Literature19
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH17
Procoagulant Platelets: Mechanisms of Generation and Action16
Management of Disseminated Intravascular Coagulation in Acute Leukemias15
The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges14
Effects and Side Effects of Platelet Transfusion14
COVID-19 and Cardiac Arrhythmias13
Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies12
Prevention and Management of Thrombosis in BCR/ABL-Negative Myeloproliferative Neoplasms12
COVID-19 Coagulopathy with Superior Mesenteric Vein Thrombosis Complicated by an Ischaemic Bowel12
From Routine to Research Laboratory: Strategies for the Diagnosis of Congenital Fibrinogen Disorders12
Understanding and Preventing Placenta-Mediated Pregnancy Complications11
Role of Platelet Cytoskeleton in Platelet Biomechanics: Current and Emerging Methodologies and Their Potential Relevance for the Investigation of Inherited Platelet Disorders11
Use of Anticoagulants in Patients with Pulmonary Hypertension11
Anti-inflammatory Strategies in Atherosclerosis11
Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice10
In Silico Hemostasis Modeling and Prediction10
A Review of FXIa Inhibition as a Novel Target for Anticoagulation10
Screening for Occult Cancer in Patients with Venous Thromboembolism: Past, Present, and Future10
Trauma-Induced Coagulopathy and Massive Bleeding: Current Hemostatic Concepts and Treatment Strategies9
COVID-19 and Myocarditis: Findings from Cardiac Magnetic Resonance Imaging and Endomyocardial Biopsies9
How to Differentiate Recurrent Deep Vein Thrombosis from Postthrombotic Syndrome8
Pulmonary Hypertension and COVID-198
Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia8
Functional Roles of the von Willebrand Factor Propeptide8
Molecular Profiling of Liver Sinusoidal Endothelial Cells in Comparison to Hepatocytes: Reflection on Which Cell Type Should Be the Target for Gene Therapy8
New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia8
Management of Antithrombin Deficiency in Pregnancy8
Current and Future Perspectives on ADAMTS13 and Thrombotic Thrombocytopenic Purpura8
Usefulness of Thrombin Generation7
Extended Half-Life Factor VIII/Factor IX Products: Assay Discrepancies and Implications for Hemophilia Management7
An Update on Laboratory Diagnostics in Haemophilia A and B7
What about Platelet Function in Platelet Concentrates?7
Anticoagulation in Pediatric Patients7
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis7
Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces7
Anticoagulation in Critically Ill Adults during Extracorporeal Circulation7
When and How to Combine Antiplatelet and Anticoagulant Drugs?7
Fine-Tuning of Platelet Responses by Serine/Threonine Protein Kinases and Phosphatases—Just the Beginning7
Bleeding Risk Assessment in Patients with Venous Thromboembolism7
Laboratory Techniques Used to Diagnose Constitutional Platelet Dysfunction6
Measuring Fibrinolysis6
Pathophysiology of the Venous Thromboembolism Risk in Preeclampsia6
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories6
COVID-19 and the Incidence of Acute Myocardial Injury6
Perinatal Management of Haemophilia6
Critical Bleeding in Acquired Hemophilia A: Bypassing Agents or Recombinant Porcine Factor VIII?6
Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?6
Venous Thrombosis and SARS-CoV-26
Microvascular Skin Manifestations Caused by COVID-196
Interventional Treatment Options in Children with Extracranial Vascular Malformations6
How the COVID-19 Pandemic Impacts Lives of Life Scientists5
How Do I Reverse Oral and Parenteral Anticoagulants?5
How to Capture the Bleeding Phenotype in FXI-Deficient Patients5
Emicizumab for All Pediatric Patients with Severe Hemophilia A5
Platelets and Matrix Metalloproteinases: A Bidirectional Interaction with Multiple Pathophysiologic Implications5
Bleeding Issues in Women Under Oral Anticoagulation5
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)—German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis5
Screening for Cancer in Patients with Acute Venous Thromboembolic Disease4
Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)4
Insights from the Hereditary Thrombotic Thrombocytopenic Purpura Registry: Discussion of Key Findings Based on Individual Cases from Switzerland4
Laboratory Assessment of Coagulation Factor XIII4
Translating Laboratory Tests into Clinical Practice: A Conceptual Framework4
Do miRNAs Have a Role in Platelet Function Regulation?4
Platelets in Myocardial Ischemia/Reperfusion Injury4
Thromboinflammation as a Driver of Venous Thromboembolism4
Assessment and Monitoring of Coagulation in Patients with COVID-19: A Review of Current Literature4
Prevention of Pregnancy Complications in Antiphospholipid Syndrome4
Flow Cytometric Assessment of AKT Signaling in Platelet Activation: An Alternative Diagnostic Tool for Small Volumes of Blood4
0.03569483757019